Oncology
542 FDA-approved drugs
Recent Approvals
FAVLYXA
FLUOROURACIL
INDICATIONS AND USAGE Fluorouracil Cream is recommended for the topical treatment of multiple actini...
2026-02-20
AVYXA HOLDINGS
IDELALISIB
IDELALISIB
patients with: Relapsed chronic lymphocytic leukemia (CLL), in combination with rituximab, in patien...
2026-02-17
NATCO
PI3K
RYBREVANT FASPROI
AMIVANTAMAB AND HYALURONIDASE-LPUJ
adult patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858...
2026-02-13
Johnson & Johnson
EGFRMET
AVOPEF
ETOPOSIDE
refractory testicular cancer in adult patients...
2026-02-13
AVYXA HOLDINGS
VYKOURA
LEUCOVORIN CALCIUM
pernicious anemia and megaloblastic anemia secondary to lack of vitamin B 12 , because of the risk o...
2026-02-03
AVYXA HOLDINGS
BONCRESA
DENOSUMAB-MOBZ
postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporot...
2025-12-19
AMNEAL PHARMS LLC
OZILTUS
DENOSUMAB-MOBZ
adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where...
2025-12-19
AMNEAL PHARMS LLC
RYBREVANT FASPRO
AMIVANTAMAB AND HYALURONIDASE-LPUJ
adult patients with locally advanced or metastatic NSCLC with EGFR exon 19 deletions or exon 21 L858...
2025-12-17
Johnson & Johnson
EGFRMET
ARMLUPEG
PEGFILGRASTIM-UNNE
the mobilization of peripheral blood progenitor cells for hematopoietic stem cell transplantation...
2025-11-28
Lupin
HYRNUO
SEVABERTINIB
adult patients with locally advanced or metastatic non-squamous non-small cell lung cancer (NSCLC) w...
2025-11-19
Bayer
HER2EGFR
KOMZIFTI
ZIFTOMENIB
adult patients with relapsed or refractory acute myeloid leukemia (AML) with a susceptible nucleopho...
2025-11-13
KURA
LOMUSTINE
LOMUSTINE
patients with: Brain tumors, primary and metastatic, following appropriate surgical and/or radiother...
2025-10-27
CARNEGIE
BLENREP
BELANTAMAB MAFODOTIN-BLMF
BLENREP is indicated in combination with bortezomib and dexamethasone for the treatment of adult pat...
2025-10-23
GSK
BCMA
FERABRIGHT
FERUMOXYTOL
magnetic resonance imaging (MRI) of the brain in adults with known or suspected malignant neoplasms ...
2025-10-16
COVIS
CONJUGATED ESTROGENS
ESTROGENS, CONJUGATED
Conjugated Estrogens Tablets are a mixture of estrogens indicated for: • Treatment of Moderate to Se...
2025-10-15
NOVAST LABS
ENOBY
DENOSUMAB-QBDE
postmenopausal women with osteoporosis at high risk for fracture, defined as a history of osteoporot...
2025-09-26
Hikma
XTRENBO
DENOSUMAB-QBDE
adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where...
2025-09-26
Hikma
INLURIYO
IMLUNESTRANT TOSYLATE
adults with estrogen receptor (ER)-positive, human epidermal growth factor receptor 2 (HER2)-negativ...
2025-09-25
Eli Lilly
KEYTRUDA QLEX
PEMBROLIZUMAB
KEYTRUDA QLEX is a combination of pembrolizumab, a programmed death receptor-1 (PD-1)-blocking antib...
2025-09-19
Merck
PD-1PD-L1PD-L2
AUKELSO
DENOSUMAB-KYQQ
adults and skeletally mature adolescents with giant cell tumor of bone that is unresectable or where...
2025-09-16
BIOCON BIOLOGICS INC
Showing 20 of 542 drugs
Top Companies
Drug Classes
Kinase Inhibitor 36
RANK Ligand Inhibitor 17
Leukocyte Growth Factor 17
Nucleoside Metabolic Inhibitor 15
Alkylating Drug 15
Programmed Death Receptor-1 Blocking Antibody 9
HER2/neu Receptor Antagonist 8
Corticosteroid 8
Endoglycosidase 7
Radioactive Diagnostic Agent 7
Quick Stats
- Total Drugs
- 542
- Companies
- 238
- Drug Classes
- 75
- Latest Approval
- 2026-02-20